New therapy cures cancer with just one injection

It neutralized not only the tumor it was injected into but malignancies all over the body.

Woman with cancer looks at her head in the mirror.
Woman with cancer looks at her head in the mirror. Credit:Getty Images.

Current cancer therapies have terrible side effects and aren’t always effective. And with things like radiotherapy and chemotherapy, the number of treatments one needs to endure makes side effects progressively worse over time. A new technique developed by researchers at Stanford University uses two agents which when combined, alert the body’s immune system to the presence of cancer, in order to eliminate it.


Just one injection can be effective for a solid tumor. Such a targeted approach could limit nasty side effects and may even be more effective than current therapies. These results were published in the journal Science Translational Medicine. Dr. Ronald Levy was the study’s senior author. He told Medical News Daily, "When we use these two agents together, we see the elimination of tumors all over the body."

Dr. Levy and colleagues injected minute levels of two “immune-stimulating agents,” into malignant solid tumors in mice. The most remarkable thing is that it treated not only the tumor it was injected into, but distant malignancies at other locations inside the body. Researchers believe it’ll be able to treat all different kinds of cancer. Using T-cells to kill cancer has long been a driving focus of immunotherapy.

Although T-cells already have incredibly powerful cancer-fighting properties, cancer cells have certain “tricks” to circumvent them, until they’ve multiplied enough to overwhelm the immune system entirely. Immunotherapy seeks to boost the immune systems capabilities, in order for it to recognize the cancer and neutralize it.

 

While current therapies can have increasingly severe side effects, this one is administered only once. Credit: Getty Images.

Clinical trials are currently underway, to see if the same effect occurs in humans. 15 patients, all with low-grade lymphoma, are taking part. Those with this particular type of cancer were selected because lymphoma is essentially a disease of the immune system and so, should show the strongest response to the therapy.

One of the agents has already gained FDA approval, while the other is part of an ongoing clinical trial as a treatment for lymphoma. This has helped streamline the process a bit. What’s also exciting is, in addition to being effective, the agents are inexpensive. “This method can ‘teach’ immune cells how to fight against that specific type of cancer,” Dr. Levy said, “which then allows them to migrate and destroy all other existing tumors.”

There are several different immunotherapy approaches in use today. Some activate the immune system everywhere in the body. Others remove the patient’s own immune cells and genetically engineer them to kill cancer. And others still turn off switches in immune cells which limit their cancer fighting abilities.

The drawbacks are that many of these experimental therapies are expensive or time consuming, or cause terrible side effects. According to Dr. Levy, “This approach bypasses the need to identify tumor-specific immune targets and doesn’t require wholesale activation of the immune system or customization of a patient’s immune cells.” The dual injection includes just one microgram (one-millionth of a gram) of each substance.

This therapy proves to be easy to administer, less expensive, and maybe even more effective than chemotherapy and radiotherapy. Credit: Getty Images.

The makeup of the injection includes a short, synthetic piece of DNA called CpG oligonucleotide. This binds to the receptor OX40, found on the surface of T-cells. The other is an antibody which binds to a T-cell and activates it. Once they make short work of the tumor, these energized T-cells travel elsewhere throughout the body, eliminating all of the same kind of cancer cells.

To test out the treatment, researchers injected 90 mice who had lymphoma with the mixture. 87 out of 90 became completely cancer-free. When tumors did recur in the remaining three, a second injection eliminated them completely, with no further recurrence. Mouse models with breast, skin, and colon cancer showed similar results. 

One stipulation, the T-cells can only target the type of cancer they first experienced. Mouse models that had lymphoma and colon cancer saw only the lymphoma eliminated. The T-cells get trained to take out a particular type of cancer, and that’s what they focus on.

Should this therapy be successful in humans, Dr. Levy and colleagues foresee it being injected after the surgical removal of a solid tumor, to make sure the cancer doesn’t recur. It might even take out any budding tumors that occur due to a genetic mutation. Dr. Levy said there’s no cancer it couldn’t treat, just so long as the immune system can infiltrate it.

To learn about other cutting-edge cancer treatments, click here.

 

‘Designer baby’ book trilogy explores the moral dilemmas humans may soon create

How would the ability to genetically customize children change society? Sci-fi author Eugene Clark explores the future on our horizon in Volume I of the "Genetic Pressure" series.

Surprising Science
  • A new sci-fi book series called "Genetic Pressure" explores the scientific and moral implications of a world with a burgeoning designer baby industry.
  • It's currently illegal to implant genetically edited human embryos in most nations, but designer babies may someday become widespread.
  • While gene-editing technology could help humans eliminate genetic diseases, some in the scientific community fear it may also usher in a new era of eugenics.
Keep reading Show less

Octopus-like creatures inhabit Jupiter’s moon, claims space scientist

A leading British space scientist thinks there is life under the ice sheets of Europa.

Jupiter's moon Europa has a huge ocean beneath its sheets of ice.

Credit: NASA/JPL-Caltech/SETI Institute
Surprising Science
  • A British scientist named Professor Monica Grady recently came out in support of extraterrestrial life on Europa.
  • Europa, the sixth largest moon in the solar system, may have favorable conditions for life under its miles of ice.
  • The moon is one of Jupiter's 79.
Keep reading Show less

Lair of giant predator worms from 20 million years ago found

Scientists discover burrows of giant predator worms that lived on the seafloor 20 million years ago.

Bobbit worm (Eunice aphroditois).

Credit: Jenny – Flickr
Surprising Science
  • Scientists in Taiwan find the lair of giant predator worms that inhabited the seafloor 20 million years ago.
  • The worm is possibly related to the modern bobbit worm (Eunice aphroditois).
  • The creatures can reach several meters in length and famously ambush their pray.
Keep reading Show less

What is the ‘self’? The 3 layers of your identity.

Answering the question of who you are is not an easy task. Let's unpack what culture, philosophy, and neuroscience have to say.

Videos
  • Who am I? It's a question that humans have grappled with since the dawn of time, and most of us are no closer to an answer.
  • Trying to pin down what makes you you depends on which school of thought you prescribe to. Some argue that the self is an illusion, while others believe that finding one's "true self" is about sincerity and authenticity.
  • In this video, author Gish Jen, Harvard professor Michael Puett, psychotherapist Mark Epstein, and neuroscientist Sam Harris discuss three layers of the self, looking through the lens of culture, philosophy, and neuroscience.
Keep reading Show less
Scroll down to load more…
Quantcast